1. Pubic Law 114-255: 21st Century Cures Act. (130 STAT. 1034; 12/13/2016; H.R. 34). Retrieved from https://www.Congress.gov.
2. Centers for Medicare and Medicaid. 2018. August 22). MEDCAC Meeting – Chimeric Antigen Receptor (CAR) T-cell Therapy and Patient Reported Outcomes. Retrieved from https://www.cms.gov/medicare-coverage-database/details/nca-proposed-decision-memo.aspx?NCAId=291.
3. Centers for Medicare and Medicaid. 2018. National Coverage Analysis Tracking Sheet for Chimeric Antigen Receptor (CAR) T-cell Therapy for Cancers (CAG-00451 N). Retrieved from https://www.cms.gov/medicare-coverage-database/details/nca-tracking-sheet.aspx?NCAId=291.
4. Centers for Medicare and Medicaid. 2019. Decision Memo for Chimeric Antigen Receptor (CAR) T-cell Therapy for Cancers (CAG-00451 N). Retrieved from https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=291.
5. Food and Drug Administration. 2017, October 18. FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma [Press release]. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-car-t-cell-therapy-treat-adults-certain-types-large-b-cell-lymphoma.